Biologic Tapering in axSpA: What Research Says and What it Means for Patients

Rheumatologist Dr. Marina Magrey discusses her latest research on biologic DMARD dose tapering in axial spondyloarthritis, outlining when it may be appropriate, its risks and benefits, and key considerations for patients.